Trial Outcomes & Findings for Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE) (NCT NCT01272076)

NCT ID: NCT01272076

Last Updated: 2014-01-20

Results Overview

In retinal areas with atrophy, light emitted from the Cirrus penetrates the sclera and choroid which are more reflecting compared with the Retinal Pigment Epithelium (RPE). The areas with higher illumination are associated with areas of Geographic Atrophy (GA), and allow to quantify how big is the area of atrophy. The study will assess the difference between Cirrus HD-OCT measurements of areas of increased illumination under the RPE to hypofluorescence areas on fundus photos as assessed manually by retina specialists.

Recruitment status

COMPLETED

Target enrollment

85 participants

Primary outcome timeframe

August 2011

Results posted on

2014-01-20

Participant Flow

85 subjects were enrolled between 1/10/2011 - 2/25/2011. The study was conducted at Retina Specialist clinics.

After enrollment a screening image of the retina is done to ensure that the area of Geographic Atrophy is consistent with the inclusion criteria. We enrolled 85 subjects, however, 19 were determined not to be eligible per study protocol. In addition, images of 14 subjects did not meet predetermined qualification criteria per study protocol.

Participant milestones

Participant milestones
Measure
Dry AMD With Geographic Atrophy
Patients diagnosed with dry AMD and geographic atrophy
Overall Study
STARTED
52
Overall Study
COMPLETED
52
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
GA Group
n=52 Participants
Patients diagnosed with dry AMD and geographic atrophy
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=5 Participants
Age, Categorical
>=65 years
50 Participants
n=5 Participants
Age, Continuous
83.6 years
STANDARD_DEVIATION 6.2 • n=5 Participants
Sex: Female, Male
Female
32 Participants
n=5 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
Region of Enrollment
United States
52 participants
n=5 Participants

PRIMARY outcome

Timeframe: August 2011

Population: Subjects with dry AMD and Geographic Atrophy. The required sample size was calculated based on previous experience with the device and its variability.

In retinal areas with atrophy, light emitted from the Cirrus penetrates the sclera and choroid which are more reflecting compared with the Retinal Pigment Epithelium (RPE). The areas with higher illumination are associated with areas of Geographic Atrophy (GA), and allow to quantify how big is the area of atrophy. The study will assess the difference between Cirrus HD-OCT measurements of areas of increased illumination under the RPE to hypofluorescence areas on fundus photos as assessed manually by retina specialists.

Outcome measures

Outcome measures
Measure
GA Group
n=52 Participants
Inter-device variability in measuring the area of Geographic Atrophy. 3 acceptable scans from 3 Cirrus HD-OCT devices (total of 9) were taken by one operator in this phase.
Difference in mm Squared of Cirrus HD-OCT Automated Measurements of the Illumination Areaa Under the RPE to Expert Manual Measurement of Areas of Hypofluorescence Typical of Geographic Atrophy (GA).
0.1 mm^2
Standard Deviation 1.9

Adverse Events

GA Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Carmelina Gordon, MD

TLC Eyecare and Laser Centers

Phone: (517) 7821213

Results disclosure agreements

  • Principal investigator is a sponsor employee The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results until the device is released on the market.
  • Publication restrictions are in place

Restriction type: OTHER